Scientists inject one tumor and watch cancer vanish across the body
🤖AI Özeti
A new cancer immunotherapy has demonstrated promising early results, marking a significant advancement after years of limited success in similar treatments. Researchers have developed a more potent CD40 agonist antibody and altered its delivery method, opting to inject it directly into tumors rather than through the bloodstream. In a small clinical trial involving 12 patients with metastatic cancers, half of the participants experienced tumor shrinkage, with two achieving complete remission.
💡AI Analizi
📚Bağlam ve Tarihsel Perspektif
The development of cancer immunotherapies has been a challenging field, often plagued by disappointments. This study represents a breakthrough that could reinvigorate interest and investment in immunotherapy as a viable treatment option for metastatic cancers.
The findings are based on a small clinical trial and further research is needed to confirm these results and assess long-term outcomes.
Orijinal Kaynak
Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.
Kaynağı Görüntüleİlgili Haberler
Tümünü Gör
NewsAI Mobil Uygulamaları
Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.